Auron Therapeuticsincis A Biotechnology Company Based In Newtonmassachusettsfounded In 2018The Company Focuses On Developing Innovative Therapies That Target Cell State Plasticityaiming To Transform Malignant Cells Into More Normal Functioning Cellsthis Approach Seeks To Improve Patient Outcomes In Oncology And Inflammatory Diseases By Addressing The Root Causes Of These Conditions Auron Therapeutics Specializes In Small Molecule Therapies Designed To Treat Various Solid Tumors And Hematological Malignanciesthe Company Utilizes Its Proprietary Ai Powered Platformaurigina Cto Analyze Single Cell Genomic Datawhich Supports The Discovery And Development Of Cancer Treatmentsauron Has Raised A Total Of $74 8 Million In Fundingwith Recent Investments Bolstering Its Research And Development Efforts
